GENAPSYS, INC.
Digital Pneumatic Microfluidic (DPM) chips and instruments for automated DNA sample and library preparation
- Sector
- Medtech
- Headquarters
- REDWOOD CITY, CA
- Founded
- 2010
- Latest Form D
- $28.5M, Mar 2021
- Total capital
- $108M
- Federal grants
- $1.9M
- 2 awards · 2015–2016
- Rank in peer group#101 of 477
- Private capital raised
- $106M
- 4 Form D · last Mar 2021
- 68 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 27
- 13 pending · first 2015
- Rank in peer group#6 of 477
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$28.5M
- Private capital raisedForm D · SEC · 3rd filing$32.5M
- Federal grantHealth and Human S · Phase II · Development of Digital Pneumatic Microfluidic Systems For NGS Sample Preparation$604K
- Federal grantHealth and Human S · Phase II · Development of Digital Pneumatic Microfluidic Systems For NGS Sample Preparation$1.3M
- Private capital raisedForm D · SEC · 2nd filing$36.5M
- Private capital raisedForm D · SEC · 1st filing$8.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#101 · top 21%
- Granted patents#6 · top 1%
- Linked publications#27 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Hesaam EsfandyarpourResearcherExecutive Officer, DirectorLinked by 9 patents
- Cui XiangminDirectorNamed in SEC Form D filings
- Frank WitneyDirectorNamed in SEC Form D filings
- Fred F. NazemDirectorNamed in SEC Form D filings
- Hamid MoghadamDirectorNamed in SEC Form D filings
- Harish SoundararajanandDirectorNamed in SEC Form D filings
Show all 11 people
- Jason MyersExecutive OfficerNamed in SEC Form D filings
- Laurent BellonExecutive OfficerNamed in SEC Form D filings
- Rakesh SachdevDirectorNamed in SEC Form D filings
- Robert ZollarsDirectorNamed in SEC Form D filings
- Xiangmin F. CuiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 27 granted of 40- PendingSystems And Methods For Nucleic Acid SequencingUSPTOApplication 17383716
- GrantedMethods And Systems For Nucleic Acid AmplificationUSPTOUS 11,332,778
- GrantedSystems And Methods For High Efficiency Electronic Sequencing And DetectionUSPTOUS 11,286,522
Show all 40 patent records
- Systems And Methods For Nucleic Acid SequencingJun 16, 2022 · Application 17383716Pending
- Methods And Systems For Nucleic Acid AmplificationMay 17, 2022 · US 11,332,778Granted
- Systems And Methods For High Efficiency Electronic Sequencing And DetectionMar 29, 2022 · US 11,286,522Granted
- Systems And Methods For Genetic And Biological AnalysisOct 26, 2021 · US 11,155,865Granted
- Systems And Methods For Genetic And Biological AnalysisJun 1, 2021 · US 11,021,748Granted
- Systems And Methods For Detection And Analysis Of Biological SpeciesMay 25, 2021 · US 11,015,219Granted
- Systems And Methods For Nucleic Acid SequencingJan 26, 2021 · US 10,900,075Granted
- Systems And Methods For Genetic And Biological AnalysisSep 29, 2020 · US 10,787,705Granted
- Systems And Methods For Biological AnalysisJul 23, 2020 · Application 16736634Pending
- Systems And Methods For Nucleic Acid SequencingJul 23, 2020 · Application 16712601Pending
- Microfluidic Devices, Systems And Methods For Sample Preparation And AnalysisJul 2, 2020 · Application 16534412Pending
- Beads For Nucleic Acid SequencingJun 16, 2020 · US 10,683,389Granted
- Systems And Methods For Genetic And Biological AnalysisApr 7, 2020 · US 10,612,091Granted
- Systems And Methods For Biological AnalysisFeb 25, 2020 · US 10,570,449Granted
- Systems And Methods For Nucleic Acid SequencingJan 28, 2020 · US 10,544,456Granted
- Methods And Systems For Nucleic Acid AmplificationJan 14, 2020 · US 10,533,218Granted
- Systems And Methods For Genetic And Biological AnalysisDec 3, 2019 · US 10,494,672Granted
- Systems And Methods For Automated Reusable Parallel Biological ReactionsNov 12, 2019 · US 10,472,674Granted
- Microfluidic Devices, Systems And Methods For Sample Preparation And AnalysisSep 17, 2019 · US 10,413,900Granted
- Systems And Methods For Biological Analysis And ComputationAug 8, 2019 · Application 16137408Pending
- Systems And Methods For Automated Reusable Parallel Biological ReactionsJul 25, 2019 · Application 16115344Pending
- Systems And Methods For Genetic And Biological AnalysisApr 23, 2019 · US 10,266,892Granted
- Systems And Methods For Genetic And Biological AnalysisApr 16, 2019 · US 10,260,095Granted
- Systems And Methods For Biological Analysis And ComputationNov 13, 2018 · US 10,125,393Granted
- Systems And Methods For Automated Reusable Parallel Biological ReactionsOct 16, 2018 · US 10,100,356Granted
- Systems And Methods For High Efficiency Electronic Sequencing And DetectionOct 9, 2018 · US 10,093,975Granted
- Methods And Systems For Nucleic Acid AmplificationNov 21, 2017 · US 9,822,401Granted
- Systems And Methods For Biological AnalysisNov 7, 2017 · US 9,809,852Granted
- Microfluidic Devices, Systems And Methods For Sample Preparation And AnalysisApr 25, 2017 · US 9,630,177Granted
- Chamber Free Nanoreactor SystemMar 9, 2017 · Application 15183406Pending
- Systems And Methods For Automated Reusable Parallel Biological ReactionsJan 3, 2017 · US 9,533,305Granted
- Systems And Methods For Genetic And Biological AnalysisMar 1, 2016 · US 9,274,077Granted
- Systems And Methods For Automated Reusable Parallel Biological ReactionsOct 6, 2015 · US 9,150,915Granted
- Methods And Systems For Electronic SequencingMar 3, 2015 · US 8,969,002Granted
- Systems And Methods For Nucleic Acid SequencingApplication 62655083Pending
- Systems And Methods For Nucleic Acid SequencingApplication PCTUS2018052072Pending
- Methods For Nucleic Acid ProcessingApplication 62418101Pending
- Systems And Methods For Nucleic Acid SequencingApplication 62375197Pending
- Systems And Methods For Redox-mediated Analysis Of Nucleic AcidsApplication 62364489Pending
- Methods And Systems For Nucleic Acid ProcessingApplication 62978735Pending
Recent research by its founders
- A Genomic Counseling Model for Population-Based Sequencing: A Pre-Post Intervention Study20246 cites
- P574: Summary of findings from comprehensive genome sequencing performed in a healthy population cohort*20240 cites
- P709: Self reported vs genetic ancestry from the GENCOV COVID-19 genomic sequencing study20240 cites
Related companies, and why
- Resolution BioscienceSimilar federal contract value in Medtech · null in contracts
- EPITEL, INCSimilar federal contract value in Medtech · null in contracts
- NANODIAGNOSTIC TECHNOLOGY, LLCSimilar federal contract value in Medtech · null in contracts
- Paxos Medical Inc.Similar federal contract value in Medtech · null in contracts
- PULVINAR NEURO LLCSimilar federal contract value in Medtech · null in contracts
- nira innovations IncSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .